In a clinical trial of fluorescence imaging based on the target FR-α, false-positive fluorescence was identified in 17/50 nonmetastatic lymph nodes caused by OTL-38 targeting of FRβ, which is expressed by tumour-associated activated macrophages [24]. The gene discussed is FOLR2; the disease is neoplasm.